NextCell Sverige AB
Developing revolutionary stem cell therapies for autoimmune diseases.
Oversikt
- 0
- Ansatte
- Ukjent
- Omsetning
- 2024
- Grunnlagt
Nøkkelbeslutningstakere
Mathias Svahn
Chief Executive Officer
Eric Gustafsson
CFO
Edvard Smith
Medical Director
Lindsay Davies
Board Member
+8 flere kontakter i Funnelfeedr
Beskrivelse
NextCell Pharma is a Swedish biotechnology company focused on revolutionizing treatments for severe and incurable diseases using stem cell therapies. The company operates three main business areas: ProTrans, Cellaviva, and QVance, all centered around advanced therapy medicinal products (ATMPs). Thei...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Ukjent
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559496728201
Beslutningstakere
12 kontakter i FunnelfeedrMathias Svahn
Chief Executive Officer
Eric Gustafsson
CFO
Edvard Smith
Medical Director
Lindsay Davies
Board Member
Sofia Sisay
Head of Clinical Trials
Hans-Peter Ekre
Chairman of the Board
Eva Sjökvist Saers
Board Member
Camilla Myhre Sandberg
Board member
Sofie Falk Jansson
CEO of Cellaviva
Andre kontakter
Per-Ola Carlsson
Advisor
Eric Strati
Advisor
Angela Vollstedt
Advisor
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
Cellaviva AB
5–9 ansatteScandinavia's largest private bank storing family stem cells for future health.
QVance AB
1–4 ansatteSpecialist quality control analytics provider for cell and gene therapies.
CELLINK Bioprinting AB
20–49 ansatteLeading provider of advanced 3D bioprinting systems and biomaterials.
Fluicell AB
10–19 ansatteDeveloping precision-engineered tissues using single-cell bioprinting technology.
Xintela AB
10–19 ansatteDeveloping stem cell and targeted cancer therapies for unmet needs.
Utforsk mer
Spørsmål om NextCell Sverige AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo